Skip to main content
Signal8

Williams Eugene

SEC insider (Form 3/4/5 filer). CIK 0001927626. Director at ProMIS Neurosciences Inc. (PMN). 8 reported Form 4/5 transactions since Sep 2024; latest on May 20, 2026. Located in TORONTO, A6.

Companies Williams Eugene has filed insider reports for

  • ProMIS Neurosciences Inc. (PMN): Director
Williams Eugene profile photo

Williams Eugene

CIK: 0001927626

Transaction Breakdown

Open Market Buys (P)4 (50.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ProMIS Neurosciences Inc. logo
PMN

ProMIS Neurosciences Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (8 total)

  • ProMIS Neurosciences Inc. logo
    PMN

    ProMIS Neurosciences Inc.

    May 20, 2026
    Award

    Option (right to buy)

    Direct
    11K shares-
  • ProMIS Neurosciences Inc. logo
    PMN

    ProMIS Neurosciences Inc.

    May 20, 2026
    Award

    Option (right to buy)

    Direct
    5.5K shares-
  • ProMIS Neurosciences Inc. logo
    PMN

    ProMIS Neurosciences Inc.

    Mar 5, 2026
    Purchase
    Direct
    2K shares at avg. $24.40$49K
  • ProMIS Neurosciences Inc. logo
    PMN

    ProMIS Neurosciences Inc.

    Mar 4, 2026
    Purchase
    Direct
    2K shares at avg. $24.00$48K
  • ProMIS Neurosciences Inc. logo
    PMN

    ProMIS Neurosciences Inc.

    Mar 3, 2026
    Purchase
    Direct
    1K shares at avg. $21.89$22K
  • ProMIS Neurosciences Inc. logo
    PMN

    ProMIS Neurosciences Inc.

    Mar 2, 2026
    Purchase
    Direct
    1K shares at avg. $22.53$23K
  • ProMIS Neurosciences Inc. logo
    PMN

    ProMIS Neurosciences Inc.

    Jun 12, 2025
    Award

    Option (right to buy)

    Direct
    20K shares-
  • ProMIS Neurosciences Inc. logo
    PMN

    ProMIS Neurosciences Inc.

    Oct 3, 2024
    Award

    Option (right to buy)

    Direct
    40K shares-

1-8 of 8